Aimei Health Technology (NASDAQ:AFJK) Sets New 52-Week High – Here’s What Happened

Shares of Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) reached a new 52-week high during trading on Wednesday . The stock traded as high as $117.48 and last traded at $112.7590, with a volume of 159318 shares changing hands. The stock had previously closed at $82.58.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (d+)” rating on shares of Aimei Health Technology in a research report on Monday. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Aimei Health Technology currently has a consensus rating of “Sell”.

Aimei Health Technology Trading Up 24.6%

The company has a market capitalization of $629.47 million, a P/E ratio of 495.26 and a beta of 0.03. The stock’s fifty day moving average is $21.83 and its 200 day moving average is $14.97.

Aimei Health Technology (NASDAQ:AFJK) last released its quarterly earnings data on Tuesday, November 18th. The company reported $0.06 earnings per share (EPS) for the quarter.

Institutional Investors Weigh In On Aimei Health Technology

Several institutional investors and hedge funds have recently bought and sold shares of the business. Polar Asset Management Partners Inc. bought a new stake in shares of Aimei Health Technology in the 1st quarter worth approximately $110,000. Wellspring Financial Advisors LLC purchased a new stake in Aimei Health Technology in the second quarter worth $133,000. Clear Street LLC boosted its holdings in Aimei Health Technology by 63.8% in the second quarter. Clear Street LLC now owns 39,525 shares of the company’s stock valued at $441,000 after acquiring an additional 15,399 shares in the last quarter. Clear Street Group Inc. purchased a new position in Aimei Health Technology during the 3rd quarter valued at $691,000. Finally, Quarry LP raised its holdings in Aimei Health Technology by 6.4% in the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock worth $1,891,000 after purchasing an additional 10,000 shares in the last quarter. Hedge funds and other institutional investors own 45.58% of the company’s stock.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.